SIMCERE PHARMAC (Germany) Today
| S2P Stock | EUR 0.81 0.01 1.22% |
Performance5 of 100
| Odds Of DistressLess than 9
|
SIMCERE PHARMAC is trading at 0.81 as of the 25th of December 2024. This is a 1.22 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.81. SIMCERE PHARMAC has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 28th of June 2024 and ending today, the 25th of December 2024. Click here to learn more.
Moving together with SIMCERE Stock
Moving against SIMCERE Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
SIMCERE Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. SIMCERE PHARMAC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SIMCERE PHARMAC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
SIMCERE PHARMAC GRP (S2P) is traded on Frankfurt Exchange in Germany and employs 6,542 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.75 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SIMCERE PHARMAC's market, we take the total number of its shares issued and multiply it by SIMCERE PHARMAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SIMCERE PHARMAC GRP classifies itself under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 2.66 B outstanding shares.
Check SIMCERE PHARMAC Probability Of Bankruptcy
Ownership AllocationSIMCERE PHARMAC GRP shows a total of 2.66 Billion outstanding shares. SIMCERE PHARMAC GRP has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.2 % of SIMCERE PHARMAC outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SIMCERE Ownership Details
SIMCERE PHARMAC GRP Risk Profiles
Although SIMCERE PHARMAC's alpha and beta are two of the key measurements used to evaluate SIMCERE PHARMAC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.07 | |||
| Semi Deviation | 2.48 | |||
| Standard Deviation | 3.04 | |||
| Variance | 9.25 |
SIMCERE Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in SIMCERE PHARMAC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Other Information on Investing in SIMCERE Stock
SIMCERE PHARMAC financial ratios help investors to determine whether SIMCERE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SIMCERE with respect to the benefits of owning SIMCERE PHARMAC security.